{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:34:51Z","timestamp":1772688891050,"version":"3.50.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1111\/bjd.14699","type":"journal-article","created":{"date-parts":[[2016,4,23]],"date-time":"2016-04-23T09:05:07Z","timestamp":1461402307000},"page":"1195-1203","source":"Crossref","is-referenced-by-count":38,"title":["A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis"],"prefix":"10.1093","volume":"175","author":[{"given":"T.","family":"Takahashi","sequence":"first","affiliation":[{"name":"Department of Dermatology; University of Tokyo Graduate School of Medicine; 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tokyo Graduate School of Medicine; 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tokyo Graduate School of Medicine; 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tokyo Graduate School of Medicine; 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Saigusa","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tokyo Graduate School of Medicine; 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Ichimura","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tokyo Graduate School of Medicine; 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Toyama","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tokyo Graduate School of Medicine; 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tokyo Graduate School of Medicine; 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Yoshizaki","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tokyo Graduate School of Medicine; 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Tamaki","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tokyo Graduate School of Medicine; 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Tada","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tokyo Graduate School of Medicine; 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sugaya","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tokyo Graduate School of Medicine; 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kadono","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tokyo Graduate School of Medicine; 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tokyo Graduate School of Medicine; 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,8,30]]},"reference":[{"key":"10.1111\/bjd.14699-BIB0001|bjd14699-cit-0001","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1346-8138.2009.00758.x","article-title":"Future treatments in systemic sclerosis","volume":"37","author":"Asano","year":"2010","journal-title":"J Dermatol"},{"key":"10.1111\/bjd.14699-BIB0002|bjd14699-cit-0002","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.4049\/jimmunol.1302005","article-title":"Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease","volume":"191","author":"Kahlenberg","year":"2013","journal-title":"J Immunol"},{"key":"10.1111\/bjd.14699-BIB0003|bjd14699-cit-0003","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1096\/fj.06-6075com","article-title":"Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin","volume":"20","author":"Yamasaki","year":"2006","journal-title":"FASEB J"},{"key":"10.1111\/bjd.14699-BIB0004|bjd14699-cit-0004","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1600-0625.2011.01327.x","article-title":"LL-37 suppresses sodium nitroprusside-induced apoptosis of systemic sclerosis dermal fibroblasts","volume":"20","author":"Kim","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.14699-BIB0005|bjd14699-cit-0005","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10067-014-2854-1","article-title":"Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease?","volume":"34","author":"Hizal","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1111\/bjd.14699-BIB0006|bjd14699-cit-0006","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1128\/MCB.20.15.5643-5652.2000","article-title":"Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor","volume":"20","author":"Spyropoulos","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1111\/bjd.14699-BIB0007|bjd14699-cit-0007","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/art.38901","article-title":"Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis","volume":"67","author":"Takahashi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1111\/bjd.14699-BIB0008|bjd14699-cit-0008","doi-asserted-by":"crossref","first-page":"34672","DOI":"10.1074\/jbc.M703907200","article-title":"Transforming growth factor-\u03b2 regulates DNA binding activity of transcription factor Fli1 by p300\/CREB-binding protein-associated factor-dependent acetylation","volume":"282","author":"Asano","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1111\/bjd.14699-BIB0009|bjd14699-cit-0009","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2353\/ajpath.2008.071049","article-title":"CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma","volume":"172","author":"Yoshizaki","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.14699-BIB0010|bjd14699-cit-0010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00403-013-1431-9","article-title":"Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis","volume":"306","author":"Ichimura","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.14699-BIB0011|bjd14699-cit-0011","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1111\/bjd.14699-BIB0012|bjd14699-cit-0012","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/bjd.14699-BIB0013|bjd14699-cit-0013","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00403-012-1307-4","article-title":"Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis","volume":"305","author":"Noda","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.14699-BIB0014|bjd14699-cit-0014","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3109\/s10165-012-0755-1","article-title":"Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosis","volume":"23","author":"Takahashi","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1111\/bjd.14699-BIB0015|bjd14699-cit-0015","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","article-title":"Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy","volume":"176","author":"Asano","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.14699-BIB0016|bjd14699-cit-0016","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/ar4529","article-title":"Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1","volume":"16","author":"Akamata","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/bjd.14699-BIB0017|bjd14699-cit-0017","doi-asserted-by":"crossref","first-page":"e32272","DOI":"10.1371\/journal.pone.0032272","article-title":"A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis","volume":"7","author":"Noda","year":"2012","journal-title":"PLoS One"},{"key":"10.1111\/bjd.14699-BIB0018|bjd14699-cit-0018","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/rheumatology\/kes379","article-title":"Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis","volume":"52","author":"Noda","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/bjd.14699-BIB0019|bjd14699-cit-0019","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/rheumatology\/keu479","article-title":"Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis","volume":"54","author":"Akamata","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/bjd.14699-BIB0020|bjd14699-cit-0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/exd.12602","article-title":"A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis","volume":"24","author":"Saigusa","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.14699-BIB0021|bjd14699-cit-0021","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/ncomms6797","article-title":"Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis","volume":"5","author":"Noda","year":"2014","journal-title":"Nat Commun"},{"key":"10.1111\/bjd.14699-BIB0022|bjd14699-cit-0022","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/art.38948","article-title":"Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated fli-1-haploinsufficient mice","volume":"67","author":"Taniguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1111\/bjd.14699-BIB0023|bjd14699-cit-0023","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.biocel.2015.06.004","article-title":"Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis","volume":"67","author":"Asano","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1111\/bjd.14699-BIB0024|bjd14699-cit-0024","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.molimm.2007.04.023","article-title":"Complex regulation of human cathelicidin gene expression: novel splice variants and 5\u02b9UTR negative regulatory element","volume":"45","author":"Elloumi","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1111\/bjd.14699-BIB0025|bjd14699-cit-0025","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/j.molimm.2008.06.020","article-title":"PU.1 and bacterial metabolites regulate the human gene CAMP encoding antimicrobial peptide LL-37 in colon epithelial cells","volume":"45","author":"Termen","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1111\/bjd.14699-BIB0026|bjd14699-cit-0026","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R","article-title":"Interferon-\u03b1 does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial","volume":"42","author":"Black","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1111\/bjd.14699-BIB0027|bjd14699-cit-0027","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2007.083246","article-title":"Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced?","volume":"68","author":"H\u00fcgle","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/bjd.14699-BIB0028|bjd14699-cit-0028","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00296-006-0282-5","article-title":"Multiple sclerosis associated with systemic sclerosis","volume":"27","author":"Pelidou","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1111\/bjd.14699-BIB0029|bjd14699-cit-0029","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s004150050390","article-title":"Systemic sclerosis and multiple sclerosis","volume":"246","author":"Spadaro","year":"1999","journal-title":"J Neurol"},{"key":"10.1111\/bjd.14699-BIB0030|bjd14699-cit-0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2169\/internalmedicine.46.6328","article-title":"Systemic sclerosis after interferon alphacon-1 therapy for hepatitis C","volume":"46","author":"Tahara","year":"2007","journal-title":"Intern Med"},{"key":"10.1111\/bjd.14699-BIB0031|bjd14699-cit-0031","first-page":"625","article-title":"Systemic sclerosis developing in association with the use of interferon alpha therapy for chronic viral hepatitis","volume":"22","author":"Solans","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/bjd.14699-BIB0032|bjd14699-cit-0032","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2133.2002.48901.x","article-title":"Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders","volume":"147","author":"Beretta","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14699-BIB0033|bjd14699-cit-0033","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/art.23451","article-title":"Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma","volume":"58","author":"Duan","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/bjd.14699-BIB0034|bjd14699-cit-0034","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2010.06.008","article-title":"The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis","volume":"59","author":"Asano","year":"2010","journal-title":"J Dermatol Sci"},{"key":"10.1111\/bjd.14699-BIB0035|bjd14699-cit-0035","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI112956","article-title":"Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons","volume":"79","author":"Duncan","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1111\/bjd.14699-BIB0036|bjd14699-cit-0036","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/labinvest.3700461","article-title":"Interferon-\u03b1 prevents apoptosis of endothelial cells after short-term exposure but induces replicative senescence after continuous stimulation","volume":"86","author":"Pammer","year":"2006","journal-title":"Lab Invest"},{"key":"10.1111\/bjd.14699-BIB0037|bjd14699-cit-0037","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI118851","article-title":"Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma","volume":"98","author":"Sgonc","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/bjd.14699-BIB0038|bjd14699-cit-0038","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2133.2011.10581.x","article-title":"Effects of bosentan on nondigital ulcers in patients with systemic sclerosis","volume":"166","author":"Taniguchi","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14699-BIB0039|bjd14699-cit-0039","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1172\/JCI17545","article-title":"An angiogenic role for the human peptide antibiotic LL-37\/hCAP-18","volume":"111","author":"Koczulla","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1111\/bjd.14699-BIB0040|bjd14699-cit-0040","doi-asserted-by":"crossref","first-page":"15136","DOI":"10.1073\/pnas.1520997112","article-title":"Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis","volume":"112","author":"Saigusa","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/bjd.14699-BIB0041|bjd14699-cit-0041","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/intimm\/dxq471","article-title":"Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells","volume":"23","author":"Suzuki","year":"2011","journal-title":"Int Immunol"},{"key":"10.1111\/bjd.14699-BIB0042|bjd14699-cit-0042","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1038\/jid.2010.120","article-title":"Epithelial cells promote fibroblast activation via IL-1\u03b1 in systemic sclerosis","volume":"130","author":"Aden","year":"2010","journal-title":"J Invest Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14699","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14699","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.14699\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:20:57Z","timestamp":1676384457000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/175\/6\/1195\/6698413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,30]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.14699","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8,30]]}}}